358 related articles for article (PubMed ID: 9102883)
21. Treatment of recurrent and resistant CAPD peritonitis by temporary withdrawal of peritoneal dialysis without removal of the catheter.
Locatelli A; Quiroga MA; De Benedetti L; Gomez M; Barone R; Barron MC
Adv Perit Dial; 1995; 11():176-8. PubMed ID: 8534698
[TBL] [Abstract][Full Text] [Related]
22. [Peritonitis in continuous ambulatory peritoneal dialysis. Experiences after 7 years].
Ejlersen E; Christiansen HD; Løkkegaard H
Ugeskr Laeger; 1989 Feb; 151(9):563-6. PubMed ID: 2922866
[TBL] [Abstract][Full Text] [Related]
23. [Clinical investigations of children with chronic renal failure and peritonitis treated with peritoneal dialysis].
Stefaniak E; Warzywoda A; Błaszczyński M; Zachwieja J; Niklas A; Maciejewski J
Pol Merkur Lekarski; 2002 Apr; 12(70):276-8. PubMed ID: 12089887
[TBL] [Abstract][Full Text] [Related]
24. The treatment of staphylococcus peritonitis in patients on continuous ambulatory peritoneal dialysis.
Drinovec J; Bren A; Gucek A; Lindic J; Kandus A; Ponikvar R
Chemioterapia; 1988 Feb; 7(1):46-8. PubMed ID: 3378276
[TBL] [Abstract][Full Text] [Related]
25. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis.
Fine RN; Salusky IB; Hall T; Lucullo L; Jordan SC; Ettenger RB
Pediatrics; 1983 May; 71(5):806-9. PubMed ID: 6835766
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
27. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
[TBL] [Abstract][Full Text] [Related]
29. [Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Evaluation of cephalothin/cephalexin monotherapy as initial treatment].
Hornstrup MK; Nielsen TG; Gahrn-Hansen B; Pedersen FB; Klausen M
Ugeskr Laeger; 1993 Nov; 155(45):3650-4. PubMed ID: 8256355
[TBL] [Abstract][Full Text] [Related]
30. Grading of exit sites cannot predict peritonitis in patients on CAPD.
Ahlmén J; Schönborg C
Adv Perit Dial; 1991; 7():117-9. PubMed ID: 1680405
[TBL] [Abstract][Full Text] [Related]
31. [Peritonitis among patients treated with continuous ambulatory peritoneal dialysis].
Bistrup C; Siboni AH; Pedersen RS
Ugeskr Laeger; 1995 Jul; 157(28):4023-6. PubMed ID: 7645077
[TBL] [Abstract][Full Text] [Related]
32. Rates and causes of peritonitis in a National Multicenter Continuous Ambulatory Peritoneal Dialysis program in Sudan: first-year experience.
Abu-Aisha H; Elhassan EA; Khamis AH; Fedail H; Kaballo B; Abdelraheem MB; Ali T; Medani S; Tammam L; Basheir I
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):565-70. PubMed ID: 17951944
[TBL] [Abstract][Full Text] [Related]
33. Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
Kleinpeter MA; Butt AA
Adv Perit Dial; 2001; 17():176-9. PubMed ID: 11510270
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal ceftriaxone].
Ragnaud JM; Bezian MC; Dupon M; Marceau C; Wone C
Pathol Biol (Paris); 1988 May; 36(5):552-6. PubMed ID: 3043356
[TBL] [Abstract][Full Text] [Related]
35. Continuous ambulatory peritoneal dialysis after intra-abdominally placed synthetic mesh for ventral hernia repair.
Schoenmaeckers EJ; Woittiez AJ; Raymakers JF; Rakic S
J Laparoendosc Adv Surg Tech A; 2011 Oct; 21(8):741-3. PubMed ID: 21657942
[TBL] [Abstract][Full Text] [Related]
36. Carrier-status for nasal staphylococci does not predict infections in CAPD patients.
Lubrich-Birkner I; Schollmeyer P; Böhler J
Adv Perit Dial; 1994; 10():154-7. PubMed ID: 7999816
[TBL] [Abstract][Full Text] [Related]
37. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
Hung SY; Chung HM
Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
[TBL] [Abstract][Full Text] [Related]
38. [Infectious complications of continuous ambulatory peritoneal dialysis].
Solaro L
G Batteriol Virol Immunol; 1986; 79(7-12):244-9. PubMed ID: 3331157
[TBL] [Abstract][Full Text] [Related]
39. Serum B2 microglobulin (B2M) in CAPD.
Duranti E; Sasdelli M
Adv Perit Dial; 1989; 5():195-9. PubMed ID: 2577410
[TBL] [Abstract][Full Text] [Related]
40. Non tuberculous mycobacterium peritonitis in continuous ambulatory peritoneal dialysis.
Youmbissi JT; Malik QT; Ajit SK; al Khursany IA; Rafi A; Karkar A
J Nephrol; 2001; 14(2):132-5. PubMed ID: 11411016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
